Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Harding Loevner Emerging Markets Equity 2024 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Harding Loevner Emerging Markets Equity)

Primary Source Intelligence • Q1 2024 Letter Analysis

Harding Loevner Emerging Markets Equity Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Harding Loevner Emerging Markets Equity. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+10.37%

Digest Analysis

Quick Take

"Emerging markets faced headwinds from US-China tensions and dollar strength, with the portfolio underperforming due to financials and healthcare exposure."

Executive Summary

Harding Loevner's Emerging Markets Equity composite returned -0.1% gross in Q1 2024, trailing the MSCI Emerging Markets Index's 2.4% return. Geopolitical tensions between the US and China weighed on markets, while the Federal Reserve's decision not to cut rates strengthened the dollar and reduced EM returns. The portfolio was hurt by weak selection in Financials, IT, and Health Care, offset by stronger Consumer Discretionary performance. Key detractors included HDFC Bank due to deposit growth concerns and WuXi companies affected by the proposed US Biosecure Act, leading to exits from both positions. The manager added new investments in MercadoLibre, Bumrungrad Hospital, and Telkom Indonesia, focusing on companies that address structural gaps in payments, healthcare, and telecommunications. The investment thesis centers on businesses that solve financial inclusion challenges while building competitive advantages, particularly in Latin America and Asia where large unbanked populations create opportunities for digital payment platforms and integrated commerce solutions.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

The manager demonstrates moderate-high conviction through specific position additions and exits with clear rationales. The detailed analysis of MercadoLibre and Bumrungrad Hospital, along with decisive exits from WuXi companies, shows conviction in investment decisions. However, the diversified portfolio structure and acknowledgment of multiple risks prevents a higher score.

Growth Outlook

38%

BearishBullish

Neutral (38%)

The manager acknowledges significant headwinds including geopolitical tensions, Federal Reserve policy, and China's economic challenges, but also identifies specific opportunities in financial inclusion and infrastructure themes. The outlook is cautious but not bearish, with selective optimism about certain sectors and regions.

Risk Appetite

15%

DefensiveAggressive

Defensive (15%)

The portfolio made selective new investments while exiting risky positions, suggesting a measured approach to risk. The manager is deploying capital in specific themes but remains cautious about broader market exposure, particularly in China-related holdings.

Capital Deployment

20%

De-riskingDeploying

De-risking (20%)

The portfolio made three new investments while exiting two positions, suggesting modest net deployment. Cash position of 3.6% indicates some dry powder, but the selective nature of new investments suggests measured rather than aggressive deployment.

Forward Guidance

10%

CautiousExpansionary

Cautious (10%)

The manager indicates continued focus on companies addressing structural gaps in emerging markets, suggesting selective deployment rather than broad-based optimism. The guidance is constructive but measured, emphasizing patience and selectivity.

Language Signal

43%

BearishBullish

Balanced (43%)

The letter contains significant discussion of risks including geopolitical tensions, regulatory concerns, and economic challenges, balanced by opportunities in specific themes. Risk language slightly outweighs opportunity language, but the tone remains professional and analytical.

Perceived Risk

72%

Low RiskElevated

Elevated Risk (72%)

The manager identifies multiple significant risks including geopolitical tensions, regulatory uncertainty, currency headwinds, and China's economic challenges. The detailed discussion of the Biosecure Act impact and broader US-China tensions indicates high awareness of systemic risks affecting the investment universe.

Opportunity Density

45%

ScarceAbundant

Selective (45%)

The manager identifies specific opportunities in financial inclusion, medical tourism, and telecommunications but emphasizes selectivity. The focus on structural themes rather than broad market opportunities suggests a moderate opportunity set requiring careful selection.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

The investment thesis focuses on long-term structural trends like financial inclusion and digital transformation in emerging markets. The manager discusses multi-year themes and company-specific developments that will play out over extended periods, indicating a patient, long-term approach to value realization.